Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

279
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
279
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

45.7K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.7K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

909
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
909
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

2.5K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.5K
Viral Mutations00:36

Viral Mutations

32.2K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.2K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Treatment and prevention of HIV/AIDS: Unfinished business.

PLoS medicine·2025
Same author

What keeps me up at night.

Science translational medicine·2023
Same author

Fitting a vaccine into the HIV prevention landscape.

Journal of the International AIDS Society·2021
Same author

Blocking α<sub>4</sub>β<sub>7</sub> integrin delays viral rebound in SHIV<sub>SF162P3</sub>-infected macaques treated with anti-HIV broadly neutralizing antibodies.

Science translational medicine·2021
Same author

An open-label phase 1 clinical trial of the anti-α<sub>4</sub>β<sub>7</sub> monoclonal antibody vedolizumab in HIV-infected individuals.

Science translational medicine·2019
Same author

Evaluation of an antibody to α<sub>4</sub>β<sub>7</sub> in the control of SIVmac239-<i>nef-stop</i> infection.

Science (New York, N.Y.)·2019
Same journal

Understanding the Clone-Censor-Weight Method in Observational Studies of Antibiotic Duration.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Treatment of Progressive Multifocal Leukoencephalopathy with Third-Party Allogeneic BK Virus T Cells.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Protection Against Recurrent Typhoid Fever Conferred by a Prior Episode: Evidence from a Large Cohort Study in Dhaka, Bangladesh.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Pre-treatment Gut Microbiome Diversity and Function Linked to Cytotoxic and Natural Killer Cell Immune Responses after N-803 Treatment in People with HIV.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Reconsidering ambiguous language in infectious disease consult recommendations.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Antibiotic Treatment Duration for Uncomplicated Monomicrobial Enterococcal Bloodstream Infection: A Multicenter Target Trial Emulation.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
查看所有相关文章

相关实验视频

Updated: Jun 6, 2025

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

16.7K

艾滋病毒/艾滋病和COVID-19:从两次大流行中共享的经验教训

Anthony S Fauci1, Gregory K Folkers2

  • 1Georgetown University: School of Medicine and McCourt School of Public Policy, Washington, DC, USA.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
|November 27, 2024
PubMed
概括
此摘要是机器生成的。

从人类免疫缺陷病毒 (HIV) /艾滋病和2019年冠状病毒病 (COVID-19) 流行病中吸取的教训对于未来传染病爆发的准备至关重要. 分析这些毁灭性流行病之间的共同点,将尽量减少未来的疫情影响,并防止全球性流行病.

关键词:
艾滋病毒/艾滋病病毒/艾滋病病毒在SARS-CoV-2/COVID-19病毒中.新兴疾病新出现的疾病.医学史 医学史全球疫情防控准备工作

更多相关视频

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.1K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.5K

相关实验视频

Last Updated: Jun 6, 2025

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

16.7K
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.1K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.5K

科学领域:

  • 全球卫生安全 全球卫生安全
  • 流行病学 流行病学
  • 传染性疾病 传染性疾病

背景情况:

  • 在过去的四十年中,许多新兴和重新出现的传染病出现了.
  • 未来的疫情是不可避免的,这给全球健康带来了重大挑战.
  • 人类免疫缺陷病毒 (HIV) /艾滋病和2019年冠状病毒病 (COVID-19) 流行病提供了关键的见解.

研究的目的:

  • 识别和分析从艾滋病毒/艾滋病和COVID-19大流行中学到的关键教训.
  • 为改善对未来传染病威胁的准备和应对提供一个框架.
  • 为了防止未来的疫情升级为全球性流行病.

主要方法:

  • 对从艾滋病毒/艾滋病和COVID-19大流行中学到的教训进行比较分析.
  • 识别微生物学,传播,病原和流行病学的共同挑战.
  • 审查反制措施的发展,包括诊断,治疗和疫苗.

主要成果:

  • 确定了艾滋病毒/艾滋病和COVID-19流行病共同的八个关键教训.
  • 这些经验教训凸显了疾病出现和应对中经常出现的挑战.
  • 了解这些共同点对于未来的流行病准备至关重要.

结论:

  • 艾滋病毒/艾滋病和COVID-19的共同经验为全球卫生安全提供了宝贵的教训.
  • 积极考虑这些教训将提高我们管理和减轻未来传染病爆发的能力.
  • 实施这些教训可以防止未来的健康危机成为全球流行病.